RYBREVANT 3520 MG SOL INJ CT FA VD TRANS X 22 ML

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1123634360052
  • GGREM 514526080046607
  • Barcode 7896212485741

What the source publishes

Holder
JANSSEN-CILAG FARMACEUTICA LTDA
Active ingredients
AMIVANTAMABE
Package
3520 MG SOL INJ CT FA VD TRANS X 22 ML
Supply regime
Tarja Vermelha
Product type
Biológico
Therapeutic class
L1G9 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, OUTROS
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:514526080046607
{
  "name": "RYBREVANT 3520 MG SOL INJ CT FA VD TRANS X 22 ML",
  "holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7896212485741"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "514526080046607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "51.780.468/0001-87",
  "priceRegime": "Regulado",
  "productName": "RYBREVANT",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "3520 MG SOL INJ CT FA VD TRANS X 22 ML",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "71367.59",
    "icms-12": "81099.56",
    "icms-17": "85985.03",
    "icms-18": "87033.63",
    "icms-19": "88108.14",
    "icms-20": "89209.49",
    "icms-21": "90338.74",
    "icms-22": "91496.89",
    "icms-23": "92685.16",
    "icms-17.5": "86506.15",
    "icms-19.5": "88655.39",
    "icms-20.5": "89770.58",
    "icms-22.5": "92087.24",
    "icms-12-alc": "72410.34",
    "icms-17-alc": "76772.33",
    "icms-18-alc": "77708.60",
    "icms-19-alc": "78667.92",
    "icms-20-alc": "79651.30",
    "icms-21-alc": "80659.58",
    "icms-22-alc": "81693.62",
    "icms-23-alc": "82754.57",
    "withoutTaxes": "63721.05",
    "icms-17.5-alc": "77237.65",
    "icms-19.5-alc": "79156.58",
    "icms-20.5-alc": "80152.23",
    "icms-22.5-alc": "82220.67"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "AMIVANTAMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "AMIVANTAMABE"
  ],
  "therapeuticClass": "L1G9 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, OUTROS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1123634360052",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "L1G9",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:514526080046607"